Scholarlink

Background <p>Periodontitis has been associated with an increased risk of pre-eclampsia, but the underlying mechanisms and causal relationship remain unclear. Oxidative stress has been implicated in both conditions, suggesting a potential mechanistic link.</p> Objectives <p>To investigate the causal relationship between periodontitis and pre-eclampsia and elucidate shared molecular pathways, with a focus on oxidative stress-related mechanisms.</p> Methods <p>We employed a multi-faceted approach combining Mendelian Randomization (MR) analysis, transcriptomic data mining, and in vitro experiments. MR analysis used genome-wide association study data to assess causality. Transcriptomic analysis of public data sets identified cross-talk genes and oxidative stress markers. In vitro experiments using HTR-8/SVneo trophoblast cells treated with Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) validated key findings.</p> Results <p>MR analysis revealed no significant causal relationship between periodontitis and pre-eclampsia. Transcriptomic analysis identified 31 cross-talk genes, including 10 periodontitis and pre-eclampsia (PD&amp;PE) marker genes and 5 oxidative stress (OS) marker genes. In vitro experiments showed increased expression of OS marker genes (ARG1, FZD1, GCLC, NQO1, and TP53INP1) and elevated reactive oxygen species levels in Pg-LPS-treated trophoblast cells. Antioxidant enzymes (SOD1, CAT, Nrf2, and HO-1) and oxidase (NOX2) were also upregulated, indicating oxidative stress response.</p> Conclusions <p>While no direct causal relationship was found, this study reveals shared molecular pathways between periodontitis and pre-eclampsia, particularly through oxidative stress mechanisms. These findings provide new insights into the periodontitis–pre-eclampsia relationship and identify potential targets for therapeutic interventions and biomarker development.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Trophoblast cell response to periodontal pathogens unveils oxidative stress networks between periodontitis and pre-eclampsia: Mendelian randomization, transcriptomic analysis, and cellular experimental validation

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月8日

查看全文
  • Lihua Hu,
  • Shuqin Liu

摘要

Background

Periodontitis has been associated with an increased risk of pre-eclampsia, but the underlying mechanisms and causal relationship remain unclear. Oxidative stress has been implicated in both conditions, suggesting a potential mechanistic link.

Objectives

To investigate the causal relationship between periodontitis and pre-eclampsia and elucidate shared molecular pathways, with a focus on oxidative stress-related mechanisms.

Methods

We employed a multi-faceted approach combining Mendelian Randomization (MR) analysis, transcriptomic data mining, and in vitro experiments. MR analysis used genome-wide association study data to assess causality. Transcriptomic analysis of public data sets identified cross-talk genes and oxidative stress markers. In vitro experiments using HTR-8/SVneo trophoblast cells treated with Porphyromonas gingivalis lipopolysaccharide (Pg-LPS) validated key findings.

Results

MR analysis revealed no significant causal relationship between periodontitis and pre-eclampsia. Transcriptomic analysis identified 31 cross-talk genes, including 10 periodontitis and pre-eclampsia (PD&PE) marker genes and 5 oxidative stress (OS) marker genes. In vitro experiments showed increased expression of OS marker genes (ARG1, FZD1, GCLC, NQO1, and TP53INP1) and elevated reactive oxygen species levels in Pg-LPS-treated trophoblast cells. Antioxidant enzymes (SOD1, CAT, Nrf2, and HO-1) and oxidase (NOX2) were also upregulated, indicating oxidative stress response.

Conclusions

While no direct causal relationship was found, this study reveals shared molecular pathways between periodontitis and pre-eclampsia, particularly through oxidative stress mechanisms. These findings provide new insights into the periodontitis–pre-eclampsia relationship and identify potential targets for therapeutic interventions and biomarker development.